A.R.T. Advisors, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$315,000
-65.5%
11,912
-78.4%
0.02%
-70.9%
Q1 2019$914,000
+25.2%
55,038
+44.4%
0.06%
+17.0%
Q4 2018$730,000
+7.0%
38,125
+192.2%
0.05%
+51.6%
Q3 2018$682,000
-32.4%
13,047
-43.8%
0.03%
-24.4%
Q2 2018$1,009,000
+134.1%
23,232
+99.5%
0.04%
+141.2%
Q1 2018$431,00011,6450.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders